Search Results 1101-1110 of 19024 for Neutrophil

1. Clinical trials - Oncology (Medical)

   MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

2. ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) - Mayo Clinic

   Absolute neutrophil count < 1.0 × 109/L or platelets < 75 × 109/L. 2. Total bilirubin > 1.5 × upper limit of normal (ULN) (participants with Gilbert's

3. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

   Evidence of myeloid engraftment (e.g., absolute neutrophil count ≥ 1.0 × 10^9/L for 3 consecutive days if ablative therapy was previously used). Use of ...

4. Romidepsin in Treating Patients with Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors with Liver Dysfunction - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.5 x 10^9/L; Platelets ≥ 100 x 10^9/L (or platelet count ≥ 30 × 10^9 cells/L in patients with lymphoma or CLL if bone ...

5. A Study to Assess the Effectiveness of Osimertinib Plus Savolitinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib - Mayo Clinic

   Participation eligibility · Absolute neutrophil count ≥1500/μL; · Haemoglobin ≥ 9 g/dL (no transfusion in the past 2 weeks); · Platelets ≥ 100,000/μL (no ...

6. Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.5 x 10^9/L without transfusion within 7 days preceding the lab assessment (obtained ≤ 14 days prior to registration).

7. A Study of R-ICE and Lenalidomide for Treating Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet count ≥ 75,000/mm^3; Total bilirubin ≤ 2 × upper limit of normal (ULN) (unless related to lymphoma or ...

8. A Study to Evaluate TVB-2640 and Trastuzumab Plus Paclitaxel or Endocrine Therapy for Treating Patients with HER2 Positive Advanced Breast Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet count; ≥ 100,000/mm^3;; Direct bilirubin ≤ 1.5 x ULN;; Aspartate transaminase (AST) ≤ 3 x ULN (≤ 5 x ...

9. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study - Mayo Clinic

   - Absolute neutrophil count (ANC) ≥ 1,000/mm^3. - Platelet count ≥ 100,000/mm^3. - Hemoglobin ≥ 8 g/dL. - Calculated (Calc.) creatinine clearance ≥ 30 ...

10. Study of Determine the Safety and Effectiveness of SHP647 as Maintenance Therapy in Subjects with Moderate-to-Severe Crohn's Disease - Mayo Clinic

    Absolute neutrophil count< 2 × 109/L (< 2000 cells/mm^3);; Serum creatinine level > 1.5 × ULN or estimated glomerular filtration rate < 30 mL/min/1.73 m^2 ...